Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia
NCT05021627 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2021-08-25
Summary
This is a multicenter randomized controlled study. By comparing patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation and pacemaker therapy, and long-term follow-up to evaluate its safety and effectiveness after surgery, in order to evaluate the safety and effectiveness of cardiac autonomic ganglion ablation in the treatment of sinus bradycardia.
Conditions
- Sinus Bradycardia
Interventions
- PROCEDURE
-
Cardiac autonomic nerve modification
Patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation. Specific anatomic ablation of the 4 major left atrial GP and aorta-superior vena cava (Ao-SVC) GP was performed. Briefly, catheter ablation was performed under the guidance of an electroanatomic mapping system (CARTO,BiosenseWebster,DiamondBar,California). After completed the electroanatomic mapping of the left atrium was complete and pulmonary vein (PV) ostia identified, presumed GP clusters were ablated 1 to 2cm outside the PV-left atrium junctions at the following sites: the left superolateral area (leftsuperior GP\[LSGP\]), the leftinfer oposterior area(left inferior GP\[LIGP\]), the right superoanterior area (rightanterior GP\[RAGP\]), the right inferoposterior area(right inferior GP\[RIGP\]), and the Ao-SVC fat pad (Ao-SVCGP), and in that sequence.
- PROCEDURE
-
Pacemaker implantation
Patients with sinus bradycardia received pacemaker implantation. The patient lay flat on the bed, puncture the subclavian vein and insert two guide wires. Cut the skin under the guide wire to make a skin bag, and stop bleeding accurately to avoid continuous bleeding of the skin bag. The pacemaker electrode is inserted into the heart cavity by guiding the guide wire, one is placed in the ventricle and the other in the atrium, and the corresponding parameters of the electrode, such as pacing threshold, impedance, etc., are measured at the same time. If the parameters are good, fix the electrode, connect the electrode with the pacemaker, place the pacemaker in the skin bag, fix the pacemaker and electrode, suture the skin layer by layer, and the operation is completed.
Sponsors & Collaborators
-
Shandong University of Traditional Chinese Medicine
collaborator OTHER -
The Second People's Hospital of Yuhuan City
collaborator UNKNOWN -
Shanghai Chest Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2026-08-31
- Completion
- 2026-08-31
More Related Trials
-
Transplanted-like Heart in Critical Ill Patients
NCT01930669 ·Status: COMPLETED ·Phase: NA
-
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China
NCT03116854 ·Status: COMPLETED
-
Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.
NCT05008250 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Refractory Angina Pectoris by Shock Wave Therapy
NCT00776568 ·Status: UNKNOWN ·Phase: PHASE3
-
Non-Pharmacologic Therapy for Neurocardiogenic Syncope
NCT00096902 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Autonomic Modulation on Symptoms in Patients With Reflux Hypersensitivity
NCT04253444 ·Status: COMPLETED ·Phase: NA
-
Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia
NCT01657136 ·Status: COMPLETED ·Phase: PHASE3
-
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Hypnosis in Autonomic Function
NCT00061009 ·Status: COMPLETED
-
Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary Syndrome
NCT03658577 ·Status: UNKNOWN
-
The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation
NCT02315313 ·Status: UNKNOWN
-
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT05997732 ·Status: RECRUITING ·Phase: PHASE4
-
The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
NCT04681612 ·Status: UNKNOWN
-
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
NCT01631409 ·Status: WITHDRAWN
-
A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled Study
NCT00516854 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
NCT05410860 ·Status: COMPLETED ·Phase: PHASE3
-
Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris
NCT01567644 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT
NCT00413712 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
NCT01251146 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
NCT04270279 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
NCT05106179 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Sympathetic Modification in Patients With Metabolic Syndrome
NCT01417247 ·Status: UNKNOWN ·Phase: NA
-
The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
NCT04942873 ·Status: UNKNOWN
-
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure
NCT02012075 ·Status: UNKNOWN ·Phase: PHASE3
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2